Riskpilot← Back to searchSign inGet full accessNemes Medical AB
ABActiveOrg 5569150187Västra Finnbodavägen 1 Sverige AbMedical specialists activities · NACE 8622Est. 20121-4 employees
Revenue 2024
SEK 3,2M
+23% vs 2023
EBITDA margin
-4.7%
-397% vs 2023
Equity ratio
8.9%
Financial strength
Net profit 2024
SEK -319K
-195% vs 2023
| Revenue | SEK 3,2M | +23% |
| EBITDA | SEK -154K | -397% |
| Net profit | SEK -319K | -195% |
| Total assets | SEK 315K | -81% |
| Equity | SEK 28K | -97% |
| Employees | — | — |
Legal name
Nemes Medical AB
Org number
5569150187
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
14 december 2012
Share capital
SEK 50 000
Employees
1-4
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva läkarverksamhet, anordna seminarier i utbildningssyfte, utveckla och sälja, exportera och importera sjukvårdsprodukter, hälsokost och hälsoprodukter samt därmed förenlig verksamhet.
Address
Västra Finnbodavägen 1 Sverige Ab
Email
info@vivagyn.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 870 | 1 692 | 1 584 | 2 633 | 3 243 |
| Staff expenses | — | — | −891 | −1 357 | −1 205 |
| EBITDA | 1 318 | 670 | 148 | 52 | −154 |
| Depreciation & amort. | −21 | −23 | −97 | −109 | −73 |
| EBIT | 1 297 | 647 | 51 | −57 | −227 |
| Net financials | −3 | 3 | −4 | −1 | −93 |
| Profit before tax | 969 | 486 | 47 | 430 | −319 |
| Tax | −209 | −96 | −11 | −95 | — |
| Net profit | 760 | 390 | 35 | 335 | −319 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 577 | 2 292 | 1 920 | 1 693 | 315 |
| Equity | 779 | 969 | 505 | 840 | 28 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 473 | 835 | 928 | 853 | 287 |
| Total debt | 473 | 835 | 928 | 853 | 287 |
EBITDA margin
-4.7%
This company
15.8%
Market median
-130% vs market
20202024
Equity ratio
8.9%
This company
38.2%
Market median
-77% vs market
20202024
Return on equity
-1140.7%
This company
18.4%
Market median
-6299% vs market
20202024
Net profit margin
-9.8%
This company
8.1%
Market median
-221% vs market
20202024
Asset turnover
10.29×
This company
1.12×
Market median
+819% vs market
20202024
Debt / equity
10.26×
This company
0.62×
Market median
-1555% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nemes Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ágnes Nemeskéri | Deputy Board Member | 0 companies |
| Bogdan Paul Dumitrescu | Deputy Board Member | 0 companies |
| Ferenc Nemeskéri | Board of Directors | 0 companies |
| Hessam Zanganeh | Board of Directors | 0 companies |